Emma Costante

Mergers, Acquisitions and Financings

• Tasktop Technologies Incorporated on its C$100-million in new financing from Sumeru Equity Partners

• Notch Therapeutics in connection with its US$85-million Series A financing

• adMare BioInnovations in connection with the C$8-million seed financing of Abdera Therapeutics

• AbCellera Biologics in connection with its US$555.5-million initial public offering of common shares on NASDAQ

• Brewster Travel Canada Inc. (an affiliate of Viad Corp.) on its acquisition of a majority equity interest in Mountain Park Lodges

• D-Wave Systems Inc. in its ongoing public transaction through a merger with a SPAC, DPCM Capital, Inc., in a deal with an implied value of US$1.2-billion

• Beijing BDStar Navigation Co., Ltd. on its acquisition of Canadian mobile positioning technology company Rx Networks Inc. with a total deal value of approximately C$31-million

• Trilogy International Partners on its US$875-million business combination with Allignvest Acquisition Corporation, a special purpose acquisition corporation (SPAC)

• Cognizant on their acquisition of Idea Couture, a privately held firm that offers digital innovation, strategy, design and technology services

• Dominion Lending Centres Group in the sale of a 60% interest to Founders Advantage Capital Corp. for C-$78 million

• Foley’s Candies in its sale to Yellow Point Equity Partners

• Concert Infrastructure, Bird Construction and Bird Capital in their successful bid to construct, finance and maintain nine public-private partnership schools in Saskatchewan

• Later.com on its acquisition by Mavrck, in a deal funded by Summit Partners

• Hutton Family Holdings Ltd. in its acquisition of the assets of Fairview Cellars Winery

• Alpha-9 Theranostics in connection with its US$75-million series B financing

• Incisive Genetics in connection with its C$12-million seed financing

Corporate Governance and Complex Commercial Transactions

• Centre for Drug Research and Development in connection with its business combination with NEOMED Institute to create adMare BioInnovations

• Acting for joint venture partners in forming various forms of joint ventures in the natural resource and manufacturing sectors

• Representing companies and shareholders in complex governance matters, including the negotiation and renegotiation of complex multi-party shareholder agreements

• Negotiating and drafting all manner of commercial and operational contracts specific to the retail, technology, agricultural and natural resource sectors

Competition and Foreign Investment

• GlaxoSmithKline in connection with the Canadian antitrust aspects of its consumer healthcare, vaccines and oncology transactions with Novartis AG

• Marine Harvest ASA on its acquisition of a significant minority interest in Grieg Seafood ASA

Emma is recognized by the following publication:

• Best Lawyers: Ones to Watch in Canada – 2022–2023 (Corporate Law)

• Co-author: British Columbia Business Corporations Act & Commentary
  LexisNexis Canada, 2023 Edition, 2023.

Admitted to the British Columbia Bar – 2015
Admitted to the Ontario Bar – 2013
JD, University of Toronto – 2012
BA (Recipient of the Brian Coghlan Memorial Prize in Economics), McGill University – 2009